.jpg?format=webp&width=780)
The study described the discovery of a previously unknown subtype of CD8+ T cells called Tc17 cells, which produce a cytokine called IL-17A that promotes the growth of pancreatic ductal adenocarcinoma (PDAC). The researchers demonstrated that Tc17 cells are present in the tumor microenvironment of PDAC and contribute to tumor growth by suppressing the activity of CD8+ T cells with an anti-tumor effect. The study suggests that targeting Tc17 cells could be a promising therapeutic strategy for PDAC.
Like
Save
Share